Innate immune sensing of HIV infection

Current Opinion in Immunology

Volumn 32, Issue , 2015, Pages 54-60

  Silvin, Aymeric ^a,b   Manel, Nicolas ^a,b  

^a INSTITUT CURIE   (France)

^b PSL RESEARCH UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR;

CD4+ T LYMPHOCYTE; CYTOSOL; EXPERIMENTAL STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOREGULATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MONOCYTE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; REVIEW; T CELL DEPLETION; VIRUS ENTRY; VIRUS PARTICLE; VIRUS REPLICATION; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DENDRITIC CELL; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MACROPHAGES; MONOCYTES; TOLL-LIKE RECEPTORS;

EID: 84921483403     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.12.003     Document Type: Review

References (75)

1. Cerboni S., Gentili M., Manel N. Diversity of pathogen sensors in dendritic cells. Adv Immunol 2013, 120:211-237.
2. Fontenot D., He H., Hanabuchi S., Nehete P.N., Zhang M., Chang M., Nehete B., Wang Y.H., Wang Y.H., Ma Z.M., et al. TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cells. Proc Natl Acad Sci U S A 2009, 106:16776-16781.
3. Lepelley A., Louis S., Sourisseau M., Law H.K., Pothlichet J., Schilte C., Chaperot L., Plumas J., Randall R.E., Si-Tahar M., et al. Innate sensing of HIV-infected cells. PLoS Pathog 2011, 7:e1001284.
4. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
5. Beignon A.S., McKenna K., Skoberne M., Manches O., DaSilva I., Kavanagh D.G., Larsson M., Gorelick R.J., Lifson J.D., Bhardwaj N. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005, 115:3265-3275.
6. O'Brien M., Manches O., Sabado R.L., Baranda S.J., Wang Y., Marie I., Rolnitzky L., Markowitz M., Margolis D.M., Levy D., et al. Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-alpha-producing and partially matured phenotype. J Clin Invest 2011, 121:1088-1101.
7. Fonteneau J.F., Larsson M., Beignon A.S., McKenna K., Dasilva I., Amara A., Liu Y.J., Lifson J.D., Littman D.R., Bhardwaj N. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J Virol 2004, 78:5223-5232.
8. Pritschet K., Donhauser N., Schuster P., Ries M., Haupt S., Kittan N.A., Korn K., Pohlmann S., Holland G., Bannert N., et al. CD4- and dynamin-dependent endocytosis of HIV-1 into plasmacytoid dendritic cells. Virology 2012, 423:152-164.
9. Patterson S., Rae A., Hockey N., Gilmour J., Gotch F. Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J Virol 2001, 75:6710-6713.
10. Keir M.E., Stoddart C.A., Linquist-Stepps V., Moreno M.E., McCune J.M. IFN-alpha secretion by type 2 predendritic cells up-regulates MHC class I in the HIV-1-infected thymus. J Immunol 2002, 168:325-331.
11. Fong L., Mengozzi M., Abbey N.W., Herndier B.G., Engleman E.G. Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation. J Virol 2002, 76:11033-11041.
12. Bloch N., O'Brien M., Norton T.D., Polsky S.B., Bhardwaj N., Landau N.R. HIV type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by Vpx. AIDS Res Hum Retroviruses 2014, 30:195-203.
13. Schmidt B., Scott I., Whitmore R.G., Foster H., Fujimura S., Schmitz J., Levy J.A. Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation. Virology 2004, 329:280-288.
14. Soumelis V., Liu Y.J. From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation. Eur J Immunol 2006, 36:2286-2292.
15. Jaehn P.S., Zaenker K.S., Schmitz J., Dzionek A. Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon. Eur J Immunol 2008, 38:1822-1832.
16. Kim S., Kaiser V., Beier E., Bechheim M., Guenthner-Biller M., Ablasser A., Berger M., Endres S., Hartmann G., Hornung V. Self-priming determines high type I IFN production by plasmacytoid dendritic cells. Eur J Immunol 2014, 44:807-818.
17. Boasso A., Herbeuval J.P., Hardy A.W., Anderson S.A., Dolan M.J., Fuchs D., Shearer G.M. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 2007, 109:3351-3359.
18. Royle C.M., Graham D.R., Sharma S., Fuchs D., Boasso A. HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs. J Immunol 2014, 193:3538-3548.
19. Chen W., Liang X., Peterson A.J., Munn D.H., Blazar B.R. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol 2008, 181:5396-5404.
20. Manches O., Munn D., Fallahi A., Lifson J., Chaperot L., Plumas J., Bhardwaj N. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism. J Clin Invest 2008, 118:3431-3439.
21. Fallarino F., Gizzi S., Mosci P., Grohmann U., Puccetti P. Tryptophan catabolism in IDO+ plasmacytoid dendritic cells. Curr Drug Metab 2007, 8:209-216.
22. Hoeffel G., Ripoche A.C., Matheoud D., Nascimbeni M., Escriou N., Lebon P., Heshmati F., Guillet J.G., Gannage M., Caillat-Zucman S., et al. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 2007, 27:481-492.
23. Stylianou E., Aukrust P., Bendtzen K., Muller F., Froland S.S. Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection. Clin Exp Immunol 2000, 119:479-485.
24. Sedaghat A.R., German J., Teslovich T.M., Cofrancesco J., Jie C.C., Talbot C.C., Siliciano R.F. Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics. J Virol 2008, 82:1870-1883.
25. Li G., Cheng M., Nunoya J., Cheng L., Guo H., Yu H., Liu Y.J., Su L., Zhang L. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog 2014, 10:e1004291.
26. Kader M., Smith A.P., Guiducci C., Wonderlich E.R., Normolle D., Watkins S.C., Barrat F.J., Barratt-Boyes S.M. Blocking TLR7- and TLR9-mediated IFN-alpha production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infection. PLoS Pathog 2013, 9:e1003530.
27. Bosinger S.E., Johnson Z.P., Folkner K.A., Patel N., Hashempour T., Jochems S.P., Del Rio Estrada P.M., Paiardini M., Lin R., Vanderford T.H., et al. Intact type I Interferon production and IRF7 function in sooty mangabeys. PLoS Pathog 2013, 9:e1003597.
28. Oswald-Richter K., Grill S.M., Shariat N., Leelawong M., Sundrud M.S., Haas D.W., Unutmaz D. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol 2004, 2:E198.
29. Granelli-Piperno A., Golebiowska A., Trumpfheller C., Siegal F.P., Steinman R.M. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc Natl Acad Sci U S A 2004, 101:7669-7674.
30. Laguette N., Sobhian B., Casartelli N., Ringeard M., Chable-Bessia C., Segeral E., Yatim A., Emiliani S., Schwartz O., Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474:654-657.
31. Manel N., Hogstad B., Wang Y., Levy D.E., Unutmaz D., Littman D.R. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 2010, 467:214-217.
32. Hrecka K., Hao C., Gierszewska M., Swanson S.K., Kesik-Brodacka M., Srivastava S., Florens L., Washburn M.P., Skowronski J. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011, 474:658-661.
33. Goldstone D.C., Ennis-Adeniran V., Hedden J.J., Groom H.C., Rice G.I., Christodoulou E., Walker P.A., Kelly G., Haire L.F., Yap M.W., et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 2011, 480:379-382.
34. Lahouassa H., Daddacha W., Hofmann H., Ayinde D., Logue E.C., Dragin L., Bloch N., Maudet C., Bertrand M., Gramberg T., et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 2012, 13:223-228.
35. Rehwinkel J., Maelfait J., Bridgeman A., Rigby R., Hayward B., Liberatore R.A., Bieniasz P.D., Towers G.J., Moita L.F., Crow Y.J., et al. SAMHD1-dependent retroviral control and escape in mice. EMBO J 2013, 32:2454-2462.
36. Ryoo J., Choi J., Oh C., Kim S., Seo M., Kim S.Y., Seo D., Kim J., White T.E., Brandariz-Nunez A., et al. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nat Med 2014, 20:936-941.
37. Goujon C., Jarrosson-Wuillème L., Bernaud J., Rigal D., Darlix J.L., Cimarelli A. With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIV(MAC). Gene Ther 2006, 13:991-994.
38. Lahaye X., Satoh T., Gentili M., Cerboni S., Conrad C., Hurbain I., El Marjou A., Lacabaratz C., Lelievre J.D., Manel N. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 2013, 39:1132-1142.
39. Rowland-Jones S.L., Whittle H.C. Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?. Nat Immunol 2007, 8:329-331.
40. Esbjornsson J., Mansson F., Kvist A., Isberg P.E., Nowroozalizadeh S., Biague A.J., da Silva Z.J., Jansson M., Fenyo E.M., Norrgren H., et al. Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection. N Engl J Med 2012, 367:224-232.
41. Gao D., Wu J., Wu Y.T., Du F., Aroh C., Yan N., Sun L., Chen Z.J. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 2013, 341:903-906.
42. Sunseri N., O'Brien M., Bhardwaj N., Landau N.R. Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells. J Virol 2011, 85:6263-6274.
43. Pertel T., Hausmann S., Morger D., Zuger S., Guerra J., Lascano J., Reinhard C., Santoni F.A., Uchil P.D., Chatel L., et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011, 472:361-365.
44. Izaguirre A., Barnes B.J., Amrute S., Yeow W.S., Megjugorac N., Dai J., Feng D., Chung E., Pitha P.M., Fitzgerald-Bocarsly P. Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J Leukoc Biol 2003, 74:1125-1138.
45. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434:772-777.
46. Gorden K.B., Gorski K.S., Gibson S.J., Kedl R.M., Kieper W.C., Qiu X., Tomai M.A., Alkan S.S., Vasilakos J.P. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 2005, 174:1259-1268.
47. Yan N., Regalado-Magdos A.D., Stiggelbout B., Lee-Kirsch M.A., Lieberman J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol 2010, 11:1005-1013.
48. Rasaiyaah J., Tan C.P., Fletcher A.J., Price A.J., Blondeau C., Hilditch L., Jacques D.A., Selwood D.L., James L.C., Noursadeghi M., et al. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 2013, 503:402-405.
49. Diget E.A., Zuwala K., Berg R.K., Laursen R.R., Soby S., Ostergaard L., Melchjorsen J., Mogensen T.H. Characterization of HIV-1 infection and innate sensing in different types of primary human monocyte-derived macrophages. Mediators Inflamm 2013, 2013:208412.
50. Chattergoon M.A., Latanich R., Quinn J., Winter M.E., Buckheit R.W., 3rd, Blankson J.N., Pardoll D., Cox A.L. HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon. PLoS Pathog 2014, 10:e1004082.
51. Manel N., Littman D.R. Hiding in plain sight: how HIV evades innate immune responses. Cell 2011, 147:271-274.
52. Cribier A., Descours B., Valadao A.L., Laguette N., Benkirane M. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep 2013, 3:1036-1043.
53. White T.E., Brandariz-Nunez A., Valle-Casuso J.C., Amie S., Nguyen L.A., Kim B., Tuzova M., Diaz-Griffero F. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. Cell Host Microbe 2013, 13:441-451.
54. Hollenbaugh J.A., Tao S., Lenzi G.M., Ryu S., Kim D.H., Diaz-Griffero F., Schinazi R.F., Kim B. dNTP pool modulation dynamics by SAMHD1 protein in monocyte-derived macrophages. Retrovirology 2014, 11:63.
55. St Gelais C., de Silva S., Hach J.C., White T.E., Diaz-Griffero F., Yount J.S., Wu L. Identification of cellular proteins interacting with the retroviral restriction factor SAMHD1. J Virol 2014, 88:5834-5844.
56. Song C., Aiken C. Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant. J Virol 2007, 81:11946-11956.
57. Sun L., Wu J., Du F., Chen X., Chen Z.J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013, 339:786-791.
58. Eckstein D.A., Penn M.L., Korin Y.D., Scripture-Adams D.D., Zack J.A., Kreisberg J.F., Roederer M., Sherman M.P., Chin P.S., Goldsmith M.A. HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. Immunity 2001, 15:671-682.
59. Monroe K.M., Yang Z., Johnson J.R., Geng X., Doitsh G., Krogan N.J., Greene W.C. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science 2014, 343:428-432.
60. Doitsh G., Cavrois M., Lassen K.G., Zepeda O., Yang Z., Santiago M.L., Hebbeler A.M., Greene W.C. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 2010, 143:789-801.
61. Doitsh G., Galloway N.L., Geng X., Yang Z., Monroe K.M., Zepeda O., Hunt P.W., Hatano H., Sowinski S., Munoz-Arias I., et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 2014, 505:509-514.
62. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009, 27:229-265.
63. Nguyen D.G., Booth A., Gould S.J., Hildreth J.E. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J Biol Chem 2003, 278:52347-52354.
64. Lemaitre B., Girardin S.E. Translation inhibition and metabolic stress pathways in the host response to bacterial pathogens. Nat Rev Microbiol 2013, 11:365-369.
65. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
66. Miller J.C., Brown B.D., Shay T., Gautier E.L., Jojic V., Cohain A., Pandey G., Leboeuf M., Elpek K.G., Helft J., et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat Immunol 2012, 13:888-899.
67. Gautier E.L., Shay T., Miller J., Greter M., Jakubzick C., Ivanov S., Helft J., Chow A., Elpek K.G., Gordonov S., et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol 2012, 13:1118-1128.
68. McGovern N., Schlitzer A., Gunawan M., Jardine L., Shin A., Poyner E., Green K., Dickinson R., Wang X.N., Low D., et al. Human dermal CD14(+) cells are a transient population of monocyte-derived macrophages. Immunity 2014, 41:465-477.
69. Iijima N., Iwasaki A. T cell memory. A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells. Science 2014, 346:93-98.
70. Hatziioannou T., Del Prete G.Q., Keele B.F., Estes J.D., McNatt M.W., Bitzegeio J., Raymond A., Rodriguez A., Schmidt F., Mac Trubey C., et al. HIV-1-induced AIDS in monkeys. Science 2014, 344:1401-1405.
71. Walker B., McMichael A. The T-cell response to HIV. Cold Spring Harb Perspect Med 2012, 2.
72. Sandler N.G., Bosinger S.E., Estes J.D., Zhu R.T., Tharp G.K., Boritz E., Levin D., Wijeyesinghe S., Makamdop K.N., del Prete G.Q., et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 2014, 511:601-605.
73. Legrand N., Ploss A., Balling R., Becker P.D., Borsotti C., Brezillon N., Debarry J., de Jong Y., Deng H., Di Santo J.P., et al. Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe 2009, 6:5-9.
74. Seamon K.J., Hansen E.C., Kadina A.P., Kashemirov B.A., McKenna C.E., Bumpus N.N., Stivers J.T. Small molecule inhibition of SAMHD1 dNTPase by tetramer destabilization. J Am Chem Soc 2014, 136:9822-9825.
75. Lee M.N., Ye C., Villani A.C., Raj T., Li W., Eisenhaure T.M., Imboywa S.H., Chipendo P.I., Ran F.A., Slowikowski K., et al. Common genetic variants modulate pathogen-sensing responses in human dendritic cells. Science 2014, 343:1246980.